ISOLATION OF SULPHATE POLYGALACTAN FROM Eucheuma alvarezii Doty AND ITS ANTICOAGULANT ACTIVITY by ., Sutrisno et al.
 
Research Article 
Volume 24 Issue 2 (2013) 86 
Indonesian J. Pharm. Vol. 24 No 2 : 86 – 92  
ISSN-p : 0126-1037 
ISOLATION OF SULPHATE POLYGALACTAN FROM Eucheuma 
alvarezii Doty AND ITS ANTICOAGULANT ACTIVITY 
 
Sutrisno*, Parlan, Hanifah Nur Al-Fath 
 
Department of Chemistry, 
Faculty of Mathematics and 
Natural Sciences, 
State University of Malang 
(Universitas Negeri Malang) 
Jl. Semarang 6 Malang 
65145, Indonesia 
 
Submitted: 30-08-2012  
Revised: 17-10-2012 
Accepted: 03-12-2012 
 
*Corresponding author 
Sutrisno 
 
Email :  
tris_chemum@yahoo.com 
ABSTRACT 
A sulphate polygalactan carrageenan was isolated from 
Euchema alvarezii Doty with yield 54.36%. The sulphate 
polygalactan was fractionated with KCl (aq) 2.5% result of a 
sulphate polygalactan of soluble fraction with the yield 60.34% 
and a sulphate polygalactanof insoluble fraction with the yield 
34.53%. Based on the properties and supported by IR spectrum, 
the sulphate polygalactan of soluble fraction is -carrageenan, 
whilethe sulphate polygalactan of insoluble fraction is                    
-carrageenan. Anticoagulant activitiy of the carrageenans were 
based on their prolongation effects on Activated Partial 
Thromboplastine Time (APTT) and Prothrombine Time (PT) of 
sodium citrate. On the assays, the carrageenans exhibited 
promising anticoagulant activities. 
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INTRODUCTION 
Many species of seaweed (marine micro 
algae) are used as food and they have also 
found use in traditional medicine because of 
their perceived health benefits.Seaweeds are 
rich sources of sulphate polysaccharides, 
including some that have become valuable 
additivesin the food industry because of their 
rheological properties as gelling and thickening 
agents. Sulphate polysaccaharides in seaweeds 
are agar, carrageenan, alginate, and laminaran. 
In addition, sulphate polysaccharides are 
recognized to possess a number of biological 
activities including anticoagulant, antiviral, and 
immuno-inflammatory activities that might find 
relevance in nutraceutical/functional food, 
cosmetic/cosmeceutical, and pharmaceutical 
applications (Jiao et al., 2011). Anticoagulant 
and anti-thrombotic activities are among the 
most widely studied properties of marine algae 
(Farias et al., 2000, Pereira et al., 2002, Mourao 
et al., 2004, Fonseca et al., 2008, and Rodrigues 
et al., 2011). Result of these researches as a rule, 
molecular size and sulphate content are among 
the most important prerequisites for these 
polymers to have anticoagulant activity. There 
are few reports of anticoagulant activity for 
sulphate polysaccharides isolated from green 
algae. Matsubara et al. (2000) isolated a highly 
sulphate galacto-arbinoglucan from the green 
algae Codium pugniformis with anticoagulant 
activity. A sulphate polygalactan with anti-
coagulant activity was also extracted from 
Codium cylindricum (Matsubara et al., 2001), 
Caulerpa racemosa with anticoagulant and 
antiviral (Ghos et al., 2004), genus of Monastroma 
as anticoagulant (Mao et al., 2008 and Zhang et 
al., 2008). The sulphate polygalactan is a 
carrageenan. Based on these result, a 
carrageenan from green algae and marine algae 
has potential as anticoagulant activity. In this 
study, sulphate polygalactan (as a carrageenan) 
was isolated from the marine red algae 
Eucheuma alvarezii Doty, and some charac-
teristics and potential anticoagulant activity of 
the sulphate polysaccharides were investigated. 
Common structure of carrageenan (as a sulphate 
polygalactan) is shown in Figure 1.  Doty is 
alternative of anticoagulant resource that can be 
developed. Objective of this research is to 
isolate a sulphate polygalactan compound from  
Euchema alvarezii Doty employing APTT and 
PT assays.  
 
METHODOLOGY 
Materials 
The marine red algae  Doty was collected 
from Waworada Bay (once of Indonesian 
island) West Nusa Tenggara – Indonesia. The 
materials was cleaned from epiphytes, washed 
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with distilled water, dried in the sun light, and 
stored at cold-room until use. The specimen 
determineated by Laboratory of Herbarium 
Bogoriense–Bogor–Indonesia. The chemicals 
that used were sodium hydroxide, sodium 
chloride, barium chloride, potassium chloride, 
hydrochloric acid, ethanol, sulphuric acid, 
hydrogen peroxide, calcium chloride, phenol (it 
all from Merck), APTT and PT reagents, 
sodium citrate, blood as human plasma, 
heparin, and filter paper Whatman No.42.  
 
Instrumentations 
The instruments in this research were 
blender, centrifuge, rotary vaccum evaporator, 
glassware, magnetic stirrer, hotplate with stirrer, 
pH meter, furnace, water-bath, analytical 
balance, Spectronic-20, Shimadzu FT-IR 
Spectrophotometer type 1600, and Shimadzu 
Coagulometer Ca-50. 
 
Procedure 
Isolation of sulphate polygalactan 
The dried powder of red algae sea weed 
Eucheuma alvarezii Doty (15g) was suspended in 
1000mL of water and the pH was adjusted to 
8.0 with aqueous solution of sodium hydroxide 
2%. The mixtures were stirred with magnetic 
stirrer for 3h at 80°C, centrifuged at 3500rpm 
until 30min, in addition it were tested by 
methylene blue to show sulphate polygalactan, 
it was indicated by purple fiber. The centrate 
was added with aqueous solution of sodium 
chloride 10%, evaporated (with rotavapor)            
up to its volume to a third the initial          
volume. Concentrated centrate poured into 
ethanol 96% (1:2.5v/v) and obtained a 
precipitate. The precipitate as sulphate 
polygalactan (carra-genan), it was then filtered 
and dried to obtain crude sulphate polygalactan 
(crude carrageenan). 
In additon, the sulphate polygalactan (or 
crude carrageenan) was dissolved in distilled 
water. The solution was added drop-wise of 
H2O2 30% while stirred until was resulted 
colourless solution. The solution was 
precipitatedby ethanol 96% and then filtered 
and dried by calcium chloride anhydrous. By 
the process given “pure” sulphate polygalactan 
(pure carrageenan). 
 
 
Fractionation of sulphate polygalactan 
Sulphate polygalactan was fractionated 
by Stancioffand Stanley method. Pure sulphate 
polygalactan (carrageenan) was dissolved in 
solution of potassium chloride 2.5% (1:100m/v), 
stirred for 1 hour, and allowed to stand at room 
temperature until 20h. The mixture was re-
stirred (for 1 h) and then centrifuged (3500rpm, 
30min), and then was decanted. Residue was 
added with 50mL of solution potassium 
chloride 2.5%, was stirred, and then centrifuged 
at 350 0rpm for 30min; it is resulted precipitate 
and centrate. The centrate was used to 
determine sulphate polygalactan of soluble 
fraction in KCl and the precipitate was used to 
determine insoluble fraction in KCl solution. 
The centrate was evaporated up to its 
volume to a third of the initial volume. 
Concentrated centrate poured into ethanol 96% 
(1:2.5v/v) and obtained a precipitate. The 
precipitate was then filtered and dried to obtain 
sulphate polygalactan (carrageenan) of soluble 
fraction in KCl 2.5%.  The part of sulphate 
polygalactan that not dissolved in KCl 2.5% 
was diluted in KCl 2.5%, centrifuged at 
3500rpm for 30min, and decanted. The residue  
was diluted in 800mL water and heated at 85°C 
for 1 hour. The result was filtered to obtain 
residue and centrate. The centrate was added 
20mL of NaCl 10%, stirred and concentrated 
by rotary vacuum evaporator. Concentrated 
centrate was precipitated with ethanol 96% 
(1:2.5v/v) and obtained a precipitate. The 
precipitate was dried and called as a sulphate 
polygalactan (carrageenan) of insoluble fraction 
in KCl 2.5% solution. 
 
Characterization and identification of 
sulphatepolygalactan. 
Total sulphate content 
The total sulphate content was 
determined by gravimetric method. “Pure” 
sulphate polygalactan (1g) was refluxed in 50 
mL HCl 0.2M for 1hour. Its mixture was 
reacted with 25mL of H2O2 10%, allowed for 
5hours and obtained clear solution. The 
solution was boiled, and reacted with BaCl2 (aq) 
10% to obtain precipitate (as BaSO4), and then 
it was separated and calculated to determine 
total sulphate content. 
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Content of total galactose 
The total galactose content was 
determined by phenol-sulphuric acid analysis 
(Dubois method) using D-galactose as 
standard.  Sulphate polygalactan (1mg)  was 
dissolved in 10mL of water. One mL of this 
solution is taken, and added 1 drop of phenol 
80% and 5mL of concentrated H2SO4. The 
solution was shaken in a water-bath at room 
temperature. In addition, made of the blank 
solution and standard solution, and then its 
absorbance were measured by Spectronic-20 at 
485nm. 
 
Solubility test 
Sulphate polygalactan was dissolved in 
water at room temperature until a saturated 
solution is obtained. 10 mL of the solution was 
taken and added with ethanol 96%, precipitate 
was obtained and calculated. Solubility (g.mL-1) 
in water of sulphate polygalactan is weight of 
precipitate (in gram) per volume of water (in 
mL).  
 
Total ash content 
Into crucible has been glowed was 
poured 0.2g of sulphate polygalactan and then 
it continued glowing to ash. The amount of ash 
that obtained as total ash content. 
 
Content of insoluble ash in water 
The ash was obtained as total ash content and 
water were boiled for 5mins and then filtered. 
The precipitate obtained was washed with hot 
water and glowed, then cooled, its result as 
insoluble ash in water.  
 
Content of insoluble ash in acid 
The ash was obtained as total ash 
content and 25mL hydrochloric acid 0.1M were 
boiled for 5 minutes and then filtered. The 
precipitate obtained was washed with hot water 
and glowed, then cooled, its result as insoluble 
ash in acid. 
 
Identification of sulphate polygalactan   
A “pure” sulphate polygalactanor 
carrageenan (see above) was identified its 
functional groups by infrared spectro-
hotometric by KBr pellet. 
 
 
 
Anticoagulant assays by APTT and PT 
All clotting assay for study of 
anticoagulant activity were carried out using 
normal human plasma similarly with carried out 
by Clinical Pathology Laboratory Baptis 
Hospital Batu – East Java. The assay was 
carried out to evaluate the prolongation effect 
on Activated Partial Thromboplastin Time 
(APTT) and Prothrombin Time (PT) of sodium 
citrat. 
Assay for APTT and PT test carried-out 
by providing 11 test-tubes containing citrate 
3.8%. In each test-tube was poured 200μL 
solution of sulphate polygalactan (total), 
sulphate polygalactan of soluble fraction, and 
sulphate polygalactan of unsoluble fraction with 
each concentration are 0.3, 0.15, and 0.05%. 
One of the 11 test-tubes was poured 200μL 
heparinsolution (5.000unit/mL), and one test-
tubes is blank. On the 11 test-tubes have been 
contained the mixture was poured 1.8 mL 
normal human blood. In addition, test-tubes 
were carried-out of APTT test with procedure 
accordingly SOP (standard operating 
procedure) of Clinical Pathology Laboratory in 
Baptis Hospital Batu – East Java. Note: 
instrument that used for APTT and PTT testsis 
Coagulometer Ca-50. The  record of cloting 
time was measured on second. 
 
RESULTS AND DISCUSSION 
Yield of sulphate polygalactan from 
seaweed 
In the present study, yield of isolation 
sulphate polygalactan from Eucheuma alvarezii 
Doty was carried out by extraction is 58.90%     
as “crude sulphate polygalactan”and 54.36%          
as “pure sulphate polygalactan”. The sulphate 
polygalactan was fractionated by solution               
of KCl (aq) 2.5%. The result of fractionation            
is 60.34% as sulphate polygalactan of soluble 
fraction  and  34.53%  as  sulphate  poly-
galactan of in soluble fraction in solution KCl 
2.5%.  
 
The properties of sulphate polygalactan 
The  characteristic  of many sulphate 
polygalactan (Table I) from red seaweed              
of Eucheuma alvarezii Doty is accordwith            
standard quality from USP XXI/NF XVI 1985.  
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According to the standard quality, current 
research goals are focused on identifying new 
properties  from  “old”  compounds from  low- 
cost natural sources for different industrial 
applications. Based on the characteristic, 
standard quality USP XXI/NF XVI 1985, and 
infra-red spectrum of these compounds, 
sulphate ploygalactan shown a carrageenan, and 
it was sugested that the polygalactan sulphate of 
soluble fraction is -carragenan, while the 
sulphate polygalactan of insoluble fraction is -
carrageenan. Structure of the carrageenan (- 
and -carrageenan) is shown in figure 1 and IR 
spectra is shown in figure 2a and 2b. 
 
Anticoagulant activity of sulphate 
polygalactan 
The research is need to discover the new 
anticoagulant compounds polygalactan 
sulphated. Sulphate polygalactan has been 
obtained last year ago. However, sulphate 
polygalactan area potentially attractive 
sourcesof macromolecules that investigated as 
anticoagulant because its structure was similar 
with heparin. Anticoagulant activity of the 
sulphate polygalactan (a carrageenan) were 
assessed using human plasma from healthy 
donors based on APTT and PT test. Assays of 
the samples using different concentration, i.e 
0.30, 0.10, and 0.05%. Result of APTT and PT 
assays shown in table II. 
Table I. Characteristic of sulphate polygalacatan from Euchema alvarezii Doty 
 
Fraction of sulphate polygalactan in KCl (aq) 2.5% 
No Properties 
Total Soluble Insoluble 
1 Total sulphate (%) 17 1 Total sulphate (%) 
2 Total galactose (%) 64.90 2 Total galactose (%) 
3 Toal ash (%) 35 3 Toal ash (%) 
4 Insoluble ash in acid (%) 17 4 Insoluble ash in acid (%) 
5 Insoluble ash in water 1.5 5 Insoluble ash in water 
7 Solubility in water (g/mL) 0.0025 7 Solubility in water (g/mL) 
 
Table II. The prolongation  effect of sulphate polygalactan on the clotting time (PTT and APTT) of 
sodium citrat (n=3) . 
 
PTT (Second) APTT (Second) 
Sample 
Concentration 
(%) Mean SD  Mean   SD 
Blank*  11.3  36.5  
Control 0.00** 12.1 0.07 36.3 0.43 
Heparin 5000*** **** - **** - 
0.30 19.7 0.14 **** - 
0.10 13.7 0.23 152.9 0.78 
Sulphate 
polygalactan (total) 
0.05 12.6 0.19 99.1 0.75 
0.30 13.2 0.29 96.1 0.49 
0.10 13.5 0.25 61.5 1.68 
Sulphate 
polygalactan 
soluble fraction in 
KCl(aq) 2.5% 
0.05 12.6 0.27 49.4 0.60 
0.30 14.5 0.27 **** - 
0.10 14.5 0.27 **** - 
Sulphate 
polygalactan 
insoluble fraction 
in KCl(aq) 2.5% 
0.05 14.2 0.27 **** - 
 
Note: * = without sample, ** = sodium citrat only, *** = unit/mL, **** = undetected 
Test-tubes number 2-12 were added sodium citrate 3.8% 
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Based on this fact, we determined the 
anticoagulant activity of these sulphated 
polysaccharides. The anticoagulant activity 
mechanism of carrageenan can be shown via 
thrombin inhibition. The anticoagulant 
properties of the carrageenan were compared 
with citrate solution. The results obtained in           
an APTT assay showed that carrageenan          
had   very   high   anticoagulant   activity   when 
compared to citrate (Table II) on concentration 
test. However, anticoagulant activity of this 
compound is lower than heparin (Matsubara et 
al., 2001). According to Boisson-Vidal et al. 
(200), polysaccharides in which the native 
sulphated pattern was intact that were more 
potentially than polymers of equivalent 
molecular weight and more potentially than the 
overall degree of sulphatation in which this 
pattern had been disrupted by partial 
desulphatation. The main basis of the 
anticoagulant activity of carrageenan appears to 
be an anti thrombic properties (Shanmugam & 
Mody, 2000). APTT is a non-specific test of the 
intrinsic system. Taken in conjunction with a 
normal prothrombin time, it is the most useful 
screening test for detecting deficiencies of 
factors VIII, IX, XI, and XII. The APTT will 
also be prolonged in any deficiency involving 
the common pathways (deficiencies of factors 
V, X, II and, to a lesser extent, fibrinogen)and 
in the presence of inhibitors. The presence of 
some therapeutic inhibitor coagulation such as 
heparin will also prolong APTT. It is important 
to exclude the possibility that such treatments 
have been employed in the initial investigation 
of prolonged APTTs. PT test reflects the 
overall efficiency of the extrinsic system. It is 
sensitive to change in factors V, VII, and X, 
and less so to factor II (prothrombin). It is also 
unsuitable for detecting minor changes in 
fibrinogen level, but may be abnormal if the 
fibrinogen level is very low or if an inhibitor is 
present. The sensitivity of the test is influenced 
by the reagent and technique used, and it is 
important to establish a reference range locally. 
The pathway measured by the prothrombin 
time. The PT reagent, often termed 
thromboplastin, contains tissue factor and 
phospholipids. Thus, the APTT test sugested 
that anticoagulant sulphate polygalactan 
isolated from E. spinosum acted on intrinsic 
and/or common pathways (Sutrisno et al., 
2010). Whereas the PT test indicated that its 
compound did not act the extrinsic pathways 
on the coagulation sascade (Rodrigues et al., 
2011). 
 
CONCLUSION 
The sulphate polygalactan isolated from 
Euchema alvarezii Dotyis a carrageenan           
with yield 54.36%. The sulphate polygalactan  
as a carrageenan. Fractionation of total sulphate  
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 Figure 1 Structure of carrageenans 
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polygalactan by KCl (aq) 2.5% were resulted a 
sulphate polygalactan of soluble fraction (yield 
60.34%) and a sulphate polygalactan of 
insoluble fraction in KCl (aq) 2.5% (yield 
34.53%). Based onthe properties and supported 
by IR spectra, the sulphate polygalactan of 
soluble KCl solution is -carragenanand the 
sulphate polygalactan of insoluble fraction is           
-carrageenan. Anticoagulant activitiy of the 
carrageenan was based on their prolongation 
effects on Activated Partial Thromboplastine 
Time (APTT) and Prothrombine Time (PT) of 
sodium citrate. On the test concentration, both 
of carrageenans (-carragenan and -carragee-
nan) exhibited anticoagulant activities by 
prolonging the APTT and PT of sodium 
citrate. 
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